Outcome data of the raw population of patients after division for type of endovascular approach
| eCAS-First Approach | MT-First Approach | P Valuea | |
|---|---|---|---|
| No. of patients | 87 | 208 | |
| Procedural and postprocedural outcome data | |||
| mTICI score 2b-3, n/N (%) | 69/87 (79%) | 179/208 (86%) | .149 |
| mTICI score 2b, n/N (%) | 26/87 (30%) | 57/208 (27%) | .666 |
| mTICI score 2c, n/N (%) | 14/87 (16%) | 46/208 (22%) | .270 |
| mTICI score 3, n/N (%) | 29/87 (33%) | 76/208 (37%) | .689 |
| GTR time, mean (SD), minutes | 89 (45) | 77 (52) | .018 |
| New territory embolism, n/N (%) | 10/87 (12%) | 32/208 (15%) | .383 |
| Intraprocedural dissection, n/N (%) | 2/87 (2%) | 7/208 (3%) | .627 |
| Early stent thrombosis, n/N (%) | 9/87 (10%) | 25/208 (12%) | .558 |
| Parenchymal hemorrhage type 2, n/N (%) | 2/87 (2%) | 14/208 (7%) | .163 |
| Parenchymal hemorrhage type 1, n/N (%) | 27/87 (31%) | 53/208 (26%) | .389 |
| Clinical outcome data | |||
| 90-day mRS score, n/N | .149 | ||
| 0 | 16/86 (19%) | 30/207 (15%) | |
| 1 | 23/86 (27%) | 42/207 (20%) | |
| 2 | 16/86 (19%) | 39/207 (19%) | |
| 3 | 8/86 (9%) | 35/207 (17%) | |
| 4 | 5/86 (6%) | 29/207 (14%) | |
| 5 | 7/86 (8%) | 16/207 (8%) | |
| 90-day mRS score = 0−2, n/N | 55/86 (64%) | 111/207 (54%) | .076 |
| 90-day mortality of any cause, n/N | 11/86 (13%) | 16/207 (8%) | .187 |
↵a Statistical significance was considered at P < .05.